Global Spasticity Treatment Market Poised to Reach USD 28.4 Billion by 2033 at a 8.1% of CAGR

Spasticity Treatment Market

According to a recent analysis by Future Market Insights (FMI), the global spasticity treatment market is projected to grow significantly over the next decade, with a valuation expected to reach US$ 28.4 billion by 2033, up from US$ 12.2 billion in 2022. This substantial growth is attributed to increased awareness and demand for advanced therapeutic solutions targeting spasticity, a condition characterized by abnormal muscle tightness or stiffness that affects a considerable portion of the global population.

The report underscores several key drivers behind the expansion of the spasticity treatment market, including the rising incidence of neurological disorders, technological advancements in treatment options, and a growing emphasis on patient-centered care. Therapeutic advancements, particularly in pharmacological treatments, intrathecal therapies, and physical rehabilitation methods, are anticipated to enhance patient outcomes and fuel market growth over the forecast period.

Key Insights from FMI’s Spasticity Treatment Market Survey:

• Market Value and Growth: The spasticity treatment market is anticipated to grow at a compound annual growth rate (CAGR) driven by increasing patient awareness and evolving treatment methods.
• Therapeutic Innovations: Pharmaceutical companies and healthcare providers are investing in new drug development, and exploring combination therapies and personalized treatment plans, resulting in improved treatment efficacy.
• Regional Demand: While North America remains a dominant market due to advanced healthcare infrastructure and supportive policies, significant growth is expected in Asia-Pacific, where healthcare investments and patient awareness are on the rise.

Future Outlook

The global spasticity treatment market is on track for accelerated growth as healthcare providers and manufacturers continue to innovate and expand their offerings to address unmet needs in spasticity management. FMI’s report predicts sustained demand for advanced treatment modalities that cater to both adult and pediatric populations affected by spasticity.

With the projected growth trajectory, FMI anticipates continued investment in research and development, further driving the market forward and enabling the introduction of cutting-edge treatment options that enhance patient care and quality of life.

Key Takeaways from Spasticity Treatment Market

• Europe holds the largest market share on the back of Germany witnessing technological advancements. Virtual reality is being used for providing immersive therapy experiences for the ones suffering from spasticity.
• The Asia-Pacific is expected to grow at the quickest rate in the spasticity treatment market with India and China leading from the front. These regions are increasingly investing in healthcare infrastructure.
• North America is expected to witness steadiness in the spasticity treatment market going forward with the US being persistent.

Competitive Landscape

Key players in the market are focused on increase their product portfolio to strengthen their position in the spasticity treatment market, and also to expand their footprint in emerging markets. The key strategy adopted by manufacturers to gain competitive edge in the market are the pricing strategies, market strategies, technological advancements, regulatory compliance and acquisition of other companies to expand their business.

For instance:

• In August 2022, Medtronic completed the acquisition of Affera. This acquisition gave Medtronic access to Affera’s Prism-1 cardiac mapping and navigation platform, which is compatible with Medtronic’s therapeutic catheters as well as a number of competing technologies.
• In January 2020, Botox manufacturer Allergan received regulatory approval to use the drug to treat young patients with upper limb spasticity.

Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the spasticity treatment market space, which are available in the full report

Key Companies Profiled

Medtronic Plc; Piramal Enterprises Ltd.; AbbVie, Inc. (Allergan); Ipsen Pharma; F. Hoffmann-La Roche Ltd; GlaxoSmithKline plc; Pfizer Inc.; Elite Pharmaceuticals Inc.; Orient Pharma; Acorda Therapeutics, Inc.; Sun Pharmaceutical Industries Ltd; Novartis AG (Alcon); Teva Pharmaceutical Industries Ltd; Zydus Cadila Healthcare Ltd.; Beximco Pharmaceuticals Ltd; Merz Pharma; Thought Technology Ltd.; UltraCare PRO; Invacare Corporation; ATI Physical Therapy; P.T. Services Rehabilitation, Inc.; Banner Health

A Full Report Overview

Key Segments Covered in Spasticity Treatment Industry Research

By Diagnosis & Treatment Type:

• Diagnosis
  • Inpatient
  • Outpatient
• Treatment Type
  • Drug
    • Baclofen
    • Tizanidine
    • Dantrolene sodium
    • Diazepam
    • Clonazepam
    • Gabapentin
  • Physical Therapy
  • Botulinum injection
  • Surgery Treatment
  • Other Treatment
• Devices
  • Reciprocal EMG-Triggered Stimulation
  • Transcutaneous Electrical Nerve Stimulation
  • Bracing and Cuff
  • Leg lifter
  • Cane and Crunches
  • Wheelchair
  • Others

By Indication:

• Cerebral Palsy
• Multiple Sclerosis
• Amyotrophic Lateral Sclerosis
• Hereditary Spastic Paraplegias
• Periventricular Leukomalacia
• Metabolic Diseases
• Traumatic Brain Injury
• Spinal Cord Injury
• Stroke
• Multiple System Atrophy
• Stiff-Person Syndrome
• Infectious Transvers Myelitis
• Encephalopathy
• Brain Tumor
• Krabbe Disease
• Johns Hopkins Disease

By Distribution Channel:

• Hospitals Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies

By Service Providers:

• Hospitals
• Ambulatory Surgical Centers
• Home Care Settings
• Specialty Clinics
• Diagnostic Centers

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube